Which of the following does Mr. Dekkers intend to change: Culture, rewards or boundaries?2. The decision to spin-off the plastics division: Is Bayer using informational or behavioral control?3. Which of the following does Mr. Dekkers intend to change: Culture, rewards or boundaries?4. What financial fact has limited decision making at Bayer?What strategic priorities is Bayer focusing on?5. Do a little internet research on co-determination and apply that concept to this case.Bayer’s CEO Injects a Dose of U.S. Risk-TakingCEO Dekkers prepares for spinoff of specialty-plastics businessBy CHRISTOPHER ALESSIpril 3, 2015 7:27 p.m. ETLEVERKUSEN, Germany—The company that invented aspirin is reinventing itself—again.Bayer AG has long been a household name to Americans who associate its iconic cross logo with the painkiller. Few know the 150-year-old German pharmaceuticals giant’s product line also includes brands from Flintstones chewable vitamins to blood thinner Xarelto.Marijn Dekkers, Bayer’s Dutch-born, U.S.-trained chief executive, is out to change that.Since he took the helm in 2010, Mr. Dekkers has rocked Bayer’s staid culture by demanding that division heads have marketing backgrounds rather than science pedigrees. He presided over the launch of five new blockbuster drugs and has beefed up the group’s over-the-counter drug business with the $14.2 billion acquisition of U.S.-based Merck